Remission of SSRI-induced akathisia after switch to nefazodone [1]

Journal of Clinical Psychiatry

Volumn 62, Issue 7, 2001, Pages 570-571

  Chelben, J ^a   Strous, R D ^a   Lustig, M ^a   Baruch, Y ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

NEFAZODONE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AKATHISIA; CASE REPORT; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; REMISSION; SYMPTOMATOLOGY;

EID: 0034888326     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n07a13     Document Type: Letter

References (20)

1. An alert to extrapyramidal side-effects from SSRIs
2. Paroxetine and akathisia
3. Sertraline and akathisia
4. Fluoxetine-induced akathisia: Clinical and theoretical implications
5. Fluoxetine, fluvoxamine and extrapyramidal tract disorders
6. 2 antagonist ritanserin
7. Selective serotonin reuptake inhibitor-induced movement disorders
8. Movement disorders associated with the serotonin selective reuptake inhibitors
9. Fluoxetine, akathisia and suicidality: Is there a causal connection?
10. Fluoxetine and suicidal behavior: Some clinical and theoretical aspects of controversy
11. Reexposure to fluoxetine after serious suicide attempts by three patients: The role of akathisia
12. Suicide associated with akathisia and depot fluphenazine treatment
13. Suicide associated with akathisia
14. Antidepressant-adverse drug reactions
15. Response of anxiety and agitation symptoms during nefazodone treatment of major depression
16. Nefazodone: Preclinical pharmacology of a new antidepressant
17. Nefazodone and akathisia
18. Cyproheptadine treatment in neuroleptic-induced akathisia
19. The influence of ritanserin, a serotonin antagonist in anxiety disorders: A double-blind placebo-controlled study versus lorazepam